Status:
COMPLETED
Discharge ALERT: Quality Improvement Initiative
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Sanofi
Conditions:
Pulmonary Embolism
Deep Vein Thrombosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Brigham and Women's Hospital will coordinate a Quality Improvement Initiative at other hospitals that focuses on whether physician notification prior to discharge of high risk VTE patients will reduce...
Detailed Description
BACKGROUND INFORMATION AND RATIONALE FOR THE STUDY Venous thromboembolism (VTE) is often avoidable in hospitalized patients because proven prevention strategies have been established for patients at ...
Eligibility Criteria
Inclusion
- Patients \> 18 years of age
- Planned discharge within 48 hours
- Cumulative VTE risk score at least 4
- Patients from Medical Services
Exclusion
- VTE risk score \<4
- Patients \<18 years of age
- Full anticoagulation therapy planned upon discharge, i.e., atrial fibrillation, mechanical heart valve, venous thromboembolism treatment, etc.
- Patient is admitted to a non-medical service, i.e., surgical service, orthopedics, obstetrics/gynecology, neurology, psychiatry, or other non-medical service
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
2515 Patients enrolled
Trial Details
Trial ID
NCT00853463
Start Date
April 1 2009
End Date
May 1 2011
Last Update
June 1 2011
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Long Beach VA Healthcare System
Long Beach, California, United States, 90822
2
UC Irvine
Orange, California, United States, 92868
3
UC Davis
Sacramento, California, United States, 95817
4
Denver VA Medical Center
Denver, Colorado, United States, 80262